Pathogenic T Cells OX 40 Ligand in Migration , But Not Monoclonal Antibody : A Critical Role for Encephalomyelitis with Anti-OX 40 Ligand Amelioration of Experimental Autoimmune

[1]  T. Aoki,et al.  Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis , 2000, The Journal of experimental medicine.

[2]  T. Noda,et al.  Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand , 2000, The Journal of experimental medicine.

[3]  J. Bluestone,et al.  Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune Encephalomyelitis1 , 2000, The Journal of Immunology.

[4]  L. Matis,et al.  Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. , 2000, The Journal of clinical investigation.

[5]  A. Weinberg,et al.  Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion1 , 2000, The Journal of Immunology.

[6]  R. Locksley,et al.  Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). , 1999, Journal of immunology.

[7]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[8]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[9]  K. Takeda,et al.  CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. , 1999, Journal of immunology.

[10]  M. Riedinger,et al.  CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40‐ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles , 1999, European journal of immunology.

[11]  A. Weinberg,et al.  Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. , 1999, Journal of immunology.

[12]  S. McDonald,et al.  Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. , 1999, Journal of immunology.

[13]  M. Croft,et al.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. , 1998, Journal of immunology.

[14]  K. Okumura,et al.  Identification of rat OX40 ligand by molecular cloning. , 1998, Biochemical and biophysical research communications.

[15]  J. Bluestone,et al.  The functional significance of epitope spreading and its regulation by co‐stimulatory molecules , 1998, Immunological reviews.

[16]  K. Toellner,et al.  CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1 , 1998, The Journal of experimental medicine.

[17]  R. Cattaneo,et al.  CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. , 1998, British journal of rheumatology.

[18]  Yuetsu Tanaka,et al.  Expression and function of OX40 ligand on human dendritic cells. , 1997, Journal of immunology.

[19]  A. Imura,et al.  Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltration , 1997, Archives of Dermatological Research.

[20]  A. Weinberg,et al.  Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. , 1997, Blood.

[21]  A. Barclay,et al.  OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand , 1996, European journal of immunology.

[22]  A. Vandenbark,et al.  Vβ CDR3 motifs associated with BP recognition are enriched in OX‐40+ spinal cord T cells of lewis rats with EAE , 1996, Journal of neuroscience research.

[23]  Yuetsu Tanaka,et al.  The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells , 1996, The Journal of experimental medicine.

[24]  W. Strober,et al.  The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response , 1996, The Journal of experimental medicine.

[25]  D. Bourdette,et al.  Selective depletion of myelin–reactive T cells with the anti–OX–40 antibody ameliorates autoimmune encephalomyelitis , 1996, Nature Medicine.

[26]  A. Weinberg,et al.  OX‐40 antibody enhances for autoantigen specific Vβ8.2+ T cells within the spinal cord of lewis rats with autoimmune encephalomyelitis , 1996, Journal of neuroscience research.

[27]  R. Karr,et al.  Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. , 1995, The Journal of clinical investigation.

[28]  H. P. Fell,et al.  Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. , 1995, Immunity.

[29]  P. Albert,et al.  Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. , 1995, Journal of immunology.

[30]  M. Seldin,et al.  Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34. , 1994, The EMBO journal.

[31]  E. Engleman,et al.  Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor , 1994, The Journal of experimental medicine.

[32]  H. Stein,et al.  The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen , 1994, European journal of immunology.

[33]  H. P. Fell,et al.  Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. , 1993, Journal of immunology.

[34]  S. Miller,et al.  Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.

[35]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[36]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.

[37]  A. Barclay,et al.  Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes‐‐a molecule related to nerve growth factor receptor. , 1990, The EMBO journal.

[38]  D. Paterson,et al.  Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. , 1987, Molecular immunology.